About this trial
The inflammatory storm in critically ill patients releases cytokines, causing systemic immune damage, which may be an important cause of multiple organ failure and even death. Inflammatory storms exacerbate the deterioration of the disease in those children. Gamma globulin may be an effective option to control inflammatory storms. However, this preliminary result needs to be verified from reliable and representative RCTs. In our study, we conducted a retrospective study on the use of gamma globulin and an unused control group. At present, the indications of IVIG are mainly focused on the neuromuscular system and the blood system. We hope to establish a more appropriate and operable evaluation table for the suitability of gamma globulin for clinical use.
Eligibility criteria
Qualifiers
children hospitalized in PICU of Children's Hospital of Fudan University
Children With Severe Infection Complicated With Inflammatory Storm
Disqualifiers
discharge within 48 hours
patients without informed consent
incomplete clinical and demographic data
Trial design
Treatments tested in this trial
- Not listed